<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01583517</url>
  </required_header>
  <id_info>
    <org_study_id>1011003897</org_study_id>
    <nct_id>NCT01583517</nct_id>
  </id_info>
  <brief_title>ERCP in Idiopathic Recurrent Acute Pancreatitis</brief_title>
  <official_title>Defining the Role of ERCP in the Evaluation and Treatment of Idiopathic Recurrent Acute Pancreatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The therapeutic impact of ERCP with sphincterotomy in the management of patients with
      idiopathic recurrent acute pancreatitis (RAP) needs further study. The investigators
      conducted a single center, feasibility, randomized trial to determine 1) the role of
      pancreatic manometry in predicting future episodes of RAP and 2) differences in the efficacy
      of no, biliary (BES) or pancreatobiliary (dual) endoscopic sphincterotomy (DES).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with idiopathic RAP, defined as ≥2 unexplained (per the treating physician) episodes
      of acute pancreatitis (based on standard criteria) requiring hospitalization, will be
      prospectively enrolled. All patients will undergo ERCP with manometry, with stratified
      randomization based on the assessment of pancreatic basal sphincter pressure. If &lt;40mmHg, the
      patient will be randomized to sham or biliary sphincterotomy (BES). If ≥40mmHg, the patient
      will be randomized to BES or pancreatobiliary (&quot;dual&quot;) sphincterotomy (DES).

      Patients and physicians will not be blinded to the assignment group. Patients will be
      followed for up to 10 years to determine 1) incidence of RAP requiring hospitalization (using
      standard definitions) or 2) interval development of chronic pancreatitis (CP).

      Differences between patients who did and did not develop RAP during follow-up will be
      compared to evaluate for factors associated with AP during follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 1997</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrent acute pancreatitis</measure>
    <time_frame>120 months</time_frame>
    <description>Patients will be followed post-ERCP for up to 10 years. The primary outcome is development of acute pancreatitis following the index ERCP, based on standard definitions.
Acute pancreatitis is defined as new onset of pancreatic-type abdominal pain with associated elevation in serum amylase or lipase &gt; 3 times the upper limit of normal, OR radiographic findings consistent with acute pancreatitis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Interval development of chronic pancreatitis</measure>
    <time_frame>120 months</time_frame>
    <description>Determine the incidence of chronic pancreatitis during prolonged follow-up. Chronic pancreatitis is defined as characteristic changes on cross sectional imaging (CT or MRI/MRCP) or ERP (Cambridge classification).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary assessment of risk factors for developing recurrent acute pancreatitis during follow-up</measure>
    <time_frame>120 months</time_frame>
    <description>A post hoc analysis will be conducted to evaluate for independent factors associated with having recurrent acute pancreatitis during follow-up</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">89</enrollment>
  <condition>Recurrent Acute Pancreatitis</condition>
  <arm_group>
    <arm_group_label>Biliary sphincterotomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cutting of the biliary sphincter muscle alone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dual sphincterotomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cutting of both the biliary and pancreatic sphincter muscles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Among patients with normal sphincter of Oddi manometry, patients will undergo no sphincterotomy (sham therapy).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Biliary sphincterotomy - Normal SOM</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Among patients with normal SOM, patients may be randomized to empiric biliary sphincterotomy alone.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biliary sphincterotomy</intervention_name>
    <description>Cutting of the biliary sphincter muscle.</description>
    <arm_group_label>Biliary sphincterotomy</arm_group_label>
    <arm_group_label>Biliary sphincterotomy - Normal SOM</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pancreatobiliary sphincterotomy</intervention_name>
    <description>Cutting of both the biliary and pancreatic sphincter muscles.</description>
    <arm_group_label>Dual sphincterotomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sham</intervention_name>
    <description>No sphincterotomy is performed in patients randomized to sham with normal SOM.</description>
    <arm_group_label>Sham</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Idiopathic recurrent acute pancreatitis, defined as two or more episodes requiring
             hospitalization

          -  ERCP with SOM planned

        Exclusion Criteria:

          -  Chronic pancreatitis

          -  Pancreas divisum

          -  Alternate etiology identified (e.g., CBD stone, IPMN)

          -  Inability to perform pancreatic manometry

          -  Pregnancy, age &lt; 18, incarceration

          -  Inability to provide informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stuart Sherman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Indiana University Health University Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Coté GA, Imperiale TF, Schmidt SE, Fogel E, Lehman G, McHenry L, Watkins J, Sherman S. Similar efficacies of biliary, with or without pancreatic, sphincterotomy in treatment of idiopathic recurrent acute pancreatitis. Gastroenterology. 2012 Dec;143(6):1502-1509.e1. doi: 10.1053/j.gastro.2012.09.006. Epub 2012 Sep 11.</citation>
    <PMID>22982183</PMID>
  </results_reference>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2012</study_first_submitted>
  <study_first_submitted_qc>April 23, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 24, 2012</study_first_posted>
  <last_update_submitted>October 8, 2014</last_update_submitted>
  <last_update_submitted_qc>October 8, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 10, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute pancreatitis</keyword>
  <keyword>ERCP</keyword>
  <keyword>Sphincterotomy</keyword>
  <keyword>Manometry</keyword>
  <keyword>Sphincter of Oddi dysfunction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

